Hematological Malignancy
Showing 1 - 25 of 59
Solid Tumor, Hematological Malignancy Trial in Fairfax (Locus Health iPhone App)
Not yet recruiting
- Solid Tumor
- Hematological Malignancy
- Locus Health iPhone App
-
Fairfax, VirginiaInova Schar Cancer Institute
Oct 24, 2023
Hematological Malignancy Trial (Thymoglobulin Injectable Product)
Not yet recruiting
- Hematological Malignancy
- Thymoglobulin Injectable Product
- (no location specified)
Sep 27, 2023
Bone Marrow Disease, Hematological Malignancy Trial in Kayseri (Musictherapy)
Active, not recruiting
- Bone Marrow Disease
- Hematological Malignancy
- Musictherapy
-
Kayseri, TurkeyKayseri City Hospital
Jun 8, 2023
Hematological Malignancy, Solid Tumor Trial (OT-A201, IMids, Bevacizumab)
Not yet recruiting
- Hematological Malignancy
- Solid Tumor
- OT-A201
- +4 more
- (no location specified)
Apr 24, 2023
Hematological Malignancy, Cancer-Related Anemia Trial in Wuhan (Shengxuening Tablet, Ferrous succinate)
Recruiting
- Hematological Malignancy
- Cancer-Related Anemia
- Shengxuening Tablet
- Ferrous succinate
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Mar 13, 2023
Participants Previously Treated With Century Therapeutics
Not yet recruiting
- Hematological Malignancy
- Solid Tumor Malignancy
- No Intervention
- (no location specified)
Mar 3, 2023
Solid Tumor, Hematological Malignancy Trial in Australia (ATG-017)
Recruiting
- Solid Tumor
- Hematological Malignancy
-
East Melbourne, Victoria, Australia
- +4 more
Jan 11, 2023
Hematological Malignancy, COVID-19 Trial in Beijing (Anti-COVID-19 Antibody SA55 for Injection)
Recruiting
- Hematological Malignancy
- COVID-19
- Anti-COVID-19 Antibody SA55 for Injection
-
Beijing, Beijing, ChinaBeijing Boren Hospital
Jan 9, 2023
Hematological Malignancy Trial in Houston (Fludarabine Phosphate, Cyclophosphamide, CAR.5/IL15-transduced CB-NK cells)
Not yet recruiting
- Hematological Malignancy
- Fludarabine Phosphate
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
The Optimization of Haploidentical Hematopoietic Stem Cell
Not yet recruiting
- Hematological Malignancy
- ATG
- Post-transplantation cyclophosphamide
-
Beijing, Beijing, ChinaPeople's Hospital of Peking University
Nov 28, 2022
Hematological Malignancy, Leukemia, Multiple Myeloma Trial in Milwaukee (Evomela, Fludarabine, Total Body Irradiation)
Recruiting
- Hematological Malignancy
- Multiple Myeloma
- Evomela
- +2 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Oct 4, 2022
Hematological Malignancy, Neutropenia Trial in Morgantown (Eravacycline)
Not yet recruiting
- Hematological Malignancy
- Neutropenia
-
Morgantown, West VirginiaAaron Cumpston
Sep 12, 2022
Following Treatment With Fate Therapeutics' Engineered Cellular
Terminated
- Hematological Malignancy
- Genetically engineered NK cells
-
Phoenix, Arizona
- +4 more
Aug 24, 2022
Hematological Malignancy Trial in Ningbo (Etoposide, Cytarabine, PEG-rhG-CSF)
Recruiting
- Hematological Malignancy
- Etoposide
- +2 more
-
Ningbo, Zhejiang, ChinaThe Affiliated People's Hospital of Ningbo University.
Aug 18, 2022
Non-Hodgkin's B-cell Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Leukemia Trial in Worldwide (MT-3724
Terminated
- Non-Hodgkin's B-cell Lymphoma
- +5 more
- MT-3724 Phase 1
- MT-3724 Phase 2
-
Tucson, Arizona
- +40 more
Jul 18, 2022
Hematological Malignancy, Lymphoma Trial in Canton (SG2501)
Recruiting
- Hematological Malignancy
- Lymphoma
-
Canton, OhioGabrail Cancer Center Research, LLC
Aug 3, 2022
DxFLEX 10C Clinical Study
Enrolling by invitation
- Hematological Malignancy
- DxFLEX 10C
-
Aliso Viejo, California
- +5 more
Jul 19, 2022
GVHD, Chronic, Hematological Malignancy Trial in Copenhagen (Lee Symptom Scala)
Active, not recruiting
- GVHD, Chronic
- Hematological Malignancy
- Lee Symptom Scala
-
Copenhagen, DenmarkRigshospitalet
Jul 14, 2022
Use of nMoABs for the Treatment of COVID-19 in Patients With HM.
Completed
- Covid19
- Hematological Malignancy
-
Bari, Italy
- +13 more
Jun 21, 2022
Hematological Malignancy Trial in Roskilde (Taste-test, Standard care)
Enrolling by invitation
- Hematological Malignancy
- Taste-test
- Standard care
-
Roskilde, DenmarkDepartment of Hematology
May 5, 2022
Solid Tumor, Hematological Malignancy Trial in Beijing (Metoprolol, metoprolol, infliximab, etanercept, tocilizumab and/or other
Recruiting
- Solid Tumor
- Hematological Malignancy
- Metoprolol
- metoprolol, infliximab, etanercept, tocilizumab and/or other agents
-
Beijing, Beijing, ChinaBiotherapeutic Department of Chinese PLA General Hospital
Apr 8, 2022
CXCR4, PET/CT, Hematological Malignancy Trial in Wuhan (68Ga-pentixafor, PET/CT)
Not yet recruiting
- CXCR4
- +2 more
- 68Ga-pentixafor
- PET/CT
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Feb 15, 2022
Solid Tumor, Hematological Malignancy Trial in Bayonne, Bordeaux, Pau (Newly obtained biopsy and Blood samples collection)
Recruiting
- Solid Tumor
- Hematological Malignancy
- Newly obtained biopsy and Blood samples collection
-
Bayonne, France
- +5 more
Feb 1, 2022
Membrane Target Detection for Leukemia Treatment
Recruiting
- Hematological Malignancy
- Study sample collection
-
Columbia, MissouriUniversity of Missouri
Dec 29, 2021